Advertisement

Topics

BioDelivery Sciences International Company Profile

02:54 EDT 21st June 2018 | BioPortfolio

We are a specialty pharmaceutical company that is exploiting its licensed and proprietary patented drug delivery technologies to develop and commercialize, either on our own or in partnerships with third parties, clinically-significant new formulations of proven therapeutics.
Our development strategy focuses on the utilization of the FDA’s 505(b)(2) approval process to obtain more timely and efficient approval of new formulations of previously approved therapeutics which incorporate our licensed drug delivery technologies. Because the 505(b)(2) approval process is designed to address new formulations of previously approved drugs, we believe it has the potential to be more cost efficient and less time consuming than other FDA approval methods

Location

2501 Aerial Center Parkway, Suite 205
Morrisville
27560
United States of America

Contact

Phone: 919 653-5160
Fax: 919 653-5161
Email: bdsi-info@bdsinternational.com


News Articles [799 Associated News Articles listed on BioPortfolio]

BioDelivery Sciences International, Inc. 2018 Q1 - Results - Earnings Call Slides

BioDelivery Sciences International's (BDSI) CEO Herm Cukier on Q1 2018 Results - Earnings Call Transcript

BioDelivery Sciences International's (BDSI) CEO Mark Sirgo on Q4 2017 Results - Earnings Call Transcript

Paolantonio Ernest Robert De Sells 64,155 Shares of BioDelivery...

BioDelivery Sciences International, Inc. CFO Paolantonio Ernest Robert De sold 64,155 shares of the company's stock in a transaction that occurred on Friday, April 6th. The stock was sold at an av...

BioDelivery Sciences raises $50M in registered direct offering

BioDelivery Sciences to Present at the 30th Annual ROTH Conference

RALEIGH, N.C., March 05, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ:BDSI), a specialty pharmaceutical company with a focus in pain management and addiction medicine...

BioDelivery Sciences Announces Launch and Availability of BELBUCA® in Canada

RALEIGH, N.C., Jan. 30, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ:BDSI) and Purdue Pharma (Canada) announced today that BELBUCA® (buprenorphine) buccal...

BioDelivery Sciences Announces Pricing of $50 Million Equity Financing

RALEIGH, N.C., May 17, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ:BDSI) today announced that it has entered into definitive agreements with existing institutional and...

PubMed Articles [1568 Associated PubMed Articles listed on BioPortfolio]

Why Food System Transformation Is Essential and How Nutrition Scientists Can Contribute.

The International Union of Nutritional Sciences held its 21st International Congress of Nutrition in October 2017 in Buenos Aires, Argentina under the theme - From Sciences to Nutrition Security. In a...

Fear of falling predicts incidence of functional disability two years later: A perspective from an international cohort study.

To study the extent to which fear of falling (FOF) is associated with the onset of functional disability over a 2-year period in older adults using self-reported and performance-based measures.

US National Cancer Institute-China Collaborative Studies on Chinese Medicine and Cancer.

Since 2007, the US National Cancer Institute (NCI) Office of Cancer Complementary and Alternative Medicine (OCCAM), together with the Cancer Institute of the China Academy of Chinese Medical Sciences ...

Correction to: Effect of renal transplantation on cognitive function in hemodialysis patients: a longitudinal study.

In the original publication, the second author's affiliation was incorrectly published as "Department of Physiology, RAK College of Medical Sciences, Ras Al Khaimah, UAE". The correct affiliation shou...

New Academicians and Foreign Members of the Chinese Academy of Sciences.

Clinical Trials [1127 Associated Clinical Trials listed on BioPortfolio]

Study of BEMA™ Fentanyl in the Treatment of Breakthrough Pain in Cancer Subjects

The purpose of this study is to evaluate the efficacy of BEMA fentanyl at any dose in the management of breakthrough pain in cancer subjects on background opioid therapy. The standard of ...

Encapsulated Cell Biodelivery of Nerve Growth Factor to Alzheimer´s Disease Patients

Cholinergic neurons in the basal forebrain project widely to the cerebral cortex and hippocampus. These neurons depend on nerve growth factor (NGF) from their target areas for survival. Im...

Study of the Safety of BEMA™ Fentanyl Use for Breakthrough Pain in Cancer Subjects on Chronic Opioid Therapy

The purpose of this study is to evaluate the safety of BEMA fentanyl at any dose in the management of breakthrough pain in cancer subjects on background opioid therapy. The standard of car...

The International Polycap Study 3 (TIPS-3)

The randomized 2x2x2 factorial design placebo controlled trial will enroll 5000 participants (women 60 years or older and men 55 years or older) without known heart disease or prior stroke...

A Bio-equivalence Study of Sofosbuvir From Elbanovir 400 mg Film Coated Tablets ( Multi-Apex Pharma, Egypt) & Sovaldi 400 mg Film Coated Tablets (Gilead Sciences, United Kingdom)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir from Elbanovir 400 mg...

Companies [2340 Associated Companies listed on BioPortfolio]

BioDelivery Sciences International, Inc.

BioDelivery Sciences (NASDAQ: BDSI) is a specialty pharmaceutical company that is leveraging its novel and proprietary patented drug delivery technologies to develop and commercia...

BioDelivery Sciences International

We are a specialty pharmaceutical company that is exploiting its licensed and proprietary patented drug delivery technologies to develop and commercialize, either on our own or in partnerships with th...

RxC International

RxC International is a life sciences management consulting firm specializing in corporate strategy, new product development, and commercialization. RxC International brings strate...

International Life Sciences, LLC

US-based medical device company International Life Sciences is committed to solving unmet clinical needs in the orthopedic and podiatric surgical communities with novel biomateria...

Sciences International

Sciences International was founded in 1993 by Dr. Elizabeth Anderson. It became part of the Tetra Tech Corporation in the fall of 2001. In June 2006, Dr. Herman Gibb was appointed as the President of ...

More Information about "BioDelivery Sciences International" on BioPortfolio

We have published hundreds of BioDelivery Sciences International news stories on BioPortfolio along with dozens of BioDelivery Sciences International Clinical Trials and PubMed Articles about BioDelivery Sciences International for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioDelivery Sciences International Companies in our database. You can also find out about relevant BioDelivery Sciences International Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record